Back to the drug test guide

THC (Marijuana) Test Evidence

Has Caused a False Positive

Methoxyisoflavone

Source Methoxyisoflavone and urine cannabinoid screening: evidence of a poorly known…, 2012

What It Found

  • A bodybuilding supplement produced positive cannabinoid screens in three volunteers after repeated doses.

Keep in Mind

  • The study involved one synthetic isoflavone and three volunteers.
  • The findings do not apply to dietary soy isoflavones.

Test Studied

  • Urine cannabinoid screen in a supplement administration study

Both sources Methoxyisoflavone and urine cannabinoid screening: evidence of a poorly known…, 2012 Lecompte et al., J Pharm Biomed Anal 2014

What It Found

  • Analysis identified the 5-methyl-7-hydroxyisoflavone metabolite.

Ibuprofen

Source Rollins et al., Clin Chem 1990

What It Found

  • A prospective study of 510 urine samples from 102 NSAID users found one false-positive cannabinoid result after a total of 1,200 mg taken over one day and one with a different NSAID.

Keep in Mind

  • This was an isolated observation on an older method.
  • It offers little basis for predicting what will happen on a current assay.

Test Studied

  • Older cannabinoid enzyme-mediated immunoassay (1990)

Naproxen

Source Rollins et al., Clin Chem 1990

What It Found

  • A prospective study of 510 urine samples from 102 NSAID users found one false-positive cannabinoid result in a patient taking naproxen regularly and one with a different NSAID.

Keep in Mind

  • This was an isolated observation on an older method.
  • It offers little basis for predicting what will happen on a current assay.

Test Studied

  • Older cannabinoid enzyme-mediated immunoassay (1990)

Cannabinol

Source Kroner et al., J Appl Lab Med 2020

What It Found

  • Cannabinol added to urine reacted on both assays.
  • It also increased the signal in samples containing small amounts of actual THC metabolite.

Keep in Mind

  • The experiments tested urine in the laboratory.
  • Cannabinol and cannabidiol are different ingredients.

Test Studied

  • EMIT II Plus and Microgenics MultiGent urine cannabinoid immunoassays

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 0.92% relative response to Cannabinol.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS cannabinoids urine application on cobas c 501, Table 4

Raltegravir

Source Hughey and Colby, Clin Chem 2019

What It Found

  • Drug-free urine spiked with raltegravir reached the cannabinoid screening cutoff at an estimated 339.5 micrograms/mL.

Keep in Mind

  • This is a laboratory concentration.
  • The study did not establish the chance of a positive urine test after a usual dose.

Test Studied

  • Abbott MULTIGENT urine cannabinoid immunoassay, 50 ng/mL cutoff

Rotigotine

Source Hughey and Colby, Clin Chem 2019

What It Found

  • Drug-free urine spiked with rotigotine reached the cannabinoid screening cutoff at an estimated 415.1 micrograms/mL.

Keep in Mind

  • This is a laboratory concentration.
  • The study did not establish the chance of a positive urine test after a usual dose.

Test Studied

  • Abbott MULTIGENT urine cannabinoid immunoassay, 50 ng/mL cutoff

Depends on the Brand of Test

Cannabidiol

Source Sholler et al., J Anal Toxicol 2022

What It Found

  • Pure CBD did not convert to THC in a controlled study that included prescription cannabidiol.

Source Wolf et al., J Anal Toxicol 2023

What It Found

  • In a separate spiking study, six cannabinoid kits did not react to CBD itself, although some reacted to its 6-hydroxy or 7-hydroxy metabolites.

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 0.08% relative response to Cannabidiol.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS cannabinoids urine application on cobas c 501, Table 4

4 sources Sholler et al., J Anal Toxicol 2022 Wolf et al., J Anal Toxicol 2023 Yates et al., J Anal Toxicol 2025 Hart et al., J Anal Toxicol 2022

Keep in Mind

  • A single administration study and spiked urine do not establish what every CBD dose or kit will do.

Test Studied

  • Urine THC immunoassays and targeted LC-MS/MS

2 sources Sholler et al., J Anal Toxicol 2022 Hart et al., J Anal Toxicol 2022

Keep in Mind

  • Products containing THC present a separate explanation.

Efavirenz

Source Oosthuizen and Laurens, Ann Clin Biochem 2012

What It Found

  • Among 30 people taking efavirenz, 28 samples reacted on Rapid Response strips.
  • All 30 were negative by GC-MS and on the three comparison immunoassays.

Test Studied

  • Rapid Response Drugs of Abuse strip, THC One Step, Roche Cannabinoids II and Beckman Coulter SYNCHRON THC2

2 sources Oosthuizen and Laurens, Ann Clin Biochem 2012 Rossi et al., Clin Chem 2006

What It Found

  • The findings implicated a glucuronidated efavirenz metabolite.

Keep in Mind

  • Results varied by product even among rapid tests.

Source Koh et al., Med J Malaysia 2013

What It Found

  • In a separate AxSYM study, 50 of 51 efavirenz-treated participants screened negative.
  • The one who screened positive reported using cannabis the previous day.

Test Studied

  • Abbott AxSYM Cannabinoids

Source Sustiva yields false positives on marijuana tests, 1998

What It Found

  • A historical drug bulletin reported that the manufacturer had observed unconfirmed THC screens during efavirenz use.

Keep in Mind

  • The notice gives no assay and no experimental data.

Test Studied

  • 1998 manufacturer's account summarized by the Critical Path AIDS Project

3 sources Oosthuizen and Laurens, Ann Clin Biochem 2012 Rossi et al., Clin Chem 2006 Koh et al., Med J Malaysia 2013

Keep in Mind

  • An efavirenz prescription alone cannot establish why an individual screen was positive.

Niflumic acid

Source Kovatsi et al., J Anal Toxicol 2010

What It Found

  • All 55 urine specimens from five people receiving niflumic acid reacted on KIMS and were negative on EMIT.
  • Spiking supported the same difference.

Keep in Mind

  • These were repeated specimens from five people on two particular assays.
  • The result should not be generalized to every drug test.

Test Studied

  • KIMS and EMIT urine cannabinoid assays

Source Boucher et al., Arch Pediatr 2009

What It Found

  • An earlier pediatric case had negative confirmatory chromatography.

Pantoprazole

Source Gomila et al., J Anal Toxicol 2017

What It Found

  • All eight pediatric samples collected at the start of pantoprazole treatment screened positive on Alere Triage.
  • One reacted on KIMS and none on DRI.
  • Pantoprazole also reacted on Alere in spiked urine.

Keep in Mind

  • Clinical samples were small, and pure pantoprazole reacted on Alere only at high concentrations.

Test Studied

  • Alere Triage TOX, KIMS Cannabinoids II, DRI Cannabinoids

2 sources Powers et al., Pain Med 2018 Vohra et al., Clin Toxicol (Phila) 2020

What It Found

  • Separate EMIT II Plus and THC One Step studies found no interference under their test conditions.

Source Felton et al., Pediatrics 2015

What It Found

  • A pediatric case report described an unexpected cannabinoid screen after a dose of intravenous pantoprazole.

Keep in Mind

  • One case is insufficient to establish causality or to generalize across other proton pump inhibitors and assay platforms.

Test Studied

  • Urine cannabinoid immunoassay in a published pediatric case

3 sources Gomila et al., J Anal Toxicol 2017 Powers et al., Pain Med 2018 Vohra et al., Clin Toxicol (Phila) 2020

Keep in Mind

  • A result depends on the kit.
  • These studies do not establish a class effect for acid suppressants.

Source Powers et al., Pain Med 2018

Test Studied

  • EMIT II Plus

Source Vohra et al., Clin Toxicol (Phila) 2020

Test Studied

  • THC One Step

A Related Drug the Test Picks Up

Delta-10 THC

Source Wolf et al., J Anal Toxicol 2023

What It Found

  • Delta-10 THC isomers reacted with urine tests aimed at delta-9 THC metabolite in laboratory experiments.

Keep in Mind

  • This reflects exposure to a related cannabinoid.
  • A broad cannabis screen cannot identify a particular isomer.
  • The laboratory must verify that its definitive method distinguishes the compounds.

Test Studied

  • Six commercial urine cannabinoid immunoassays

Source Patton et al., J Anal Toxicol 2025

What It Found

  • In fortified urine the (6aR,9R) carboxy metabolite of delta-10 THC reacted at the delta-9 metabolite cutoff.

Keep in Mind

  • All 77 authentic urines containing delta-10-THC-COOH also contained delta-9-THC-COOH, so the study could not isolate the cause in those patients.

Test Studied

  • Beckman Coulter EMIT II Plus Cannabinoid immunoassay

Delta-8 THC

4 sources Wolf et al., J Anal Toxicol 2023 Mullen et al., J Anal Toxicol 2023 ElSohly et al., J Anal Toxicol 1990 Yates et al., J Anal Toxicol 2025

What It Found

  • Delta-8 THC and its metabolites reacted with urine tests aimed at delta-9 THC metabolite in laboratory experiments.

Keep in Mind

  • This reflects exposure to a related cannabinoid.
  • A broad cannabis screen cannot identify a particular isomer.
  • The laboratory must verify that its definitive method distinguishes the compounds.

Test Studied

  • Commercial urine cannabinoid immunoassays, including Abbott TDx and antibody-based ELISA assays

Source Rosano et al., J Anal Toxicol 2023

What It Found

  • The study showed how resolving delta-8- and delta-9-carboxy-THC isomers changes interpretation of cannabinoid confirmation.

Keep in Mind

  • This result concerns confirmatory-method selectivity.
  • A class screen cannot distinguish individual THC isomers.

Test Studied

  • Urine confirmation by isomer-selective UPLC-MS/MS

Source Akpunonu et al., Am J Case Rep 2021

What It Found

  • A child's urine screened positive after delta-8 THC gummies.
  • Specialized testing confirmed delta-8 exposure in urine and serum.

Test Studied

  • Hospital urine cannabinoid screen with specialized LC-QTOF-MS testing

Source Karas et al., J Anal Toxicol 2024

What It Found

  • Nearly one-third of 2,939 immunoassay-positive urines contained delta-8 THC-COOH without delta-9 THC-COOH at the 15 ng/mL confirmation cutoff.

Keep in Mind

  • The study population was selected for an already positive screen.
  • The fraction is not the chance of testing positive after using delta-8.

Test Studied

  • Urine cannabinoid immunoassay, cutoff 50 ng/mL, with isomer-selective LC-MS/MS

2 sources ElSohly et al., J Anal Toxicol 1990 Akpunonu et al., Am J Case Rep 2021

Keep in Mind

  • A standard cannabinoid screen cannot determine which THC isomer someone used.

Hexahydrocannabinol

Source Tsujikawa et al., Forensic Toxicol 2025

What It Found

  • Two carboxy-HHC isomers triggered three urine THC panels in spiking experiments.
  • All three panels also reacted to a urine specimen from one reported HHC user.

Keep in Mind

  • The response depended on the isomer and the device.

Test Studied

  • Urine cannabinoid panels, including Driven Flow THC L50, IVeX-Screen THC L50-S and AccuSign THC

Source Lucuta et al., Forensic Sci Int 2025

What It Found

  • Urine cannabinoid tests became positive after oral or inhaled HHC product exposure in the small self-administration study.

Keep in Mind

  • The paper separately evaluated oral fluid and plasma.
  • The urine result applies to the tested device and products.

Test Studied

  • DrugScreen urine strip, 25 ng/mL THC-COOH cutoff

Source Höfert et al., Drug Test Anal 2024

What It Found

  • The authors reported that the evaluated urine strips could detect HHC-related exposure, with performance dependent on the tested compound and device.

Keep in Mind

  • The traffic series measured HHC in serum or plasma.
  • It was separate from the urine strip experiments.

Test Studied

  • Urine cannabinoid test strips included in a multi-matrix HHC evaluation

3 sources Helander et al., Scand J Clin Lab Invest 2024 Tsujikawa et al., Forensic Toxicol 2025 Yates et al., J Anal Toxicol 2025

Keep in Mind

  • A class screen cannot distinguish HHC exposure from delta-9 THC exposure.

Also cited: Wolf et al., J Anal Toxicol 2023

Delta-8 tetrahydrocannabivarin

Source Sempio et al., Forensic Toxicol 2026

What It Found

  • After healthy volunteers took delta-8 THCV, 70 of 80 pooled urine samples from the first eight hours screened positive.
  • LC–MS/MS found no delta-9 THC carboxy metabolite in those samples and identified metabolites of delta-8 THCV.

Keep in Mind

  • This was a controlled study of a related cannabinoid.
  • The count refers to pooled samples, and the result cannot predict what other products or tests will show.

Test Studied

  • Urine immunoassay targeting the delta-9 THC carboxy metabolite, with LC–MS/MS comparison

The Test Is Made to Find It

Dronabinol

Source Koch et al., Clin Chim Acta 2020

What It Found

  • Five dronabinol-treated patients provided urine in which the study detected THC metabolites.
  • The prescription medicine supplies delta-9 THC, the substance a cannabis test is designed to detect.

Keep in Mind

  • A routine positive THC-metabolite result alone does not establish the source or show impairment.

Test Studied

  • Urine cannabinoid metabolites measured by LC-MS/MS

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 1.3% for delta-9-THC, 14% for 11-hydroxy-THC and 34% for THC-COOH glucuronide relative response.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS cannabinoids urine application on cobas c 501, Table 4

CBD products containing delta-9 THC

Source Sholler et al., J Anal Toxicol 2022

What It Found

  • After vaporized CBD-dominant cannabis containing measured delta-9 THC, three of 18 participants produced samples meeting the study’s confirmatory THC-metabolite cutoff.
  • The product supplied real THC.

Keep in Mind

  • The measured product and dose matter.

Test Studied

  • Urine cannabinoid immunoassays and targeted LC-MS/MS

Source Goggin and Janis, Clin Toxicol (Phila) 2021

What It Found

  • Some users of commercial CBD products excreted actual THC metabolites.

Keep in Mind

  • Commercial formulations and histories vary.
  • Urine alone cannot identify the specific product supplying the THC.

Test Studied

  • Specific urine cannabinoid metabolite measurement in users of commercial CBD products

Both sources Sholler et al., J Anal Toxicol 2022 Goggin and Janis, Clin Toxicol (Phila) 2021

What It Found

  • A positive urine result can therefore reflect THC exposure from the product.

Keep in Mind

  • A label saying CBD alone does not tell how much THC was present.

A Problem With the Urine Sample

Baby wash contamination

Source Cotten et al., Clin Biochem 2012

What It Found

  • Adding certain baby wash products to drug-free urine generated a THC screening signal.
  • Investigators traced the effect to specific surfactants.

Keep in Mind

  • This is a specimen-collection issue.
  • The study did not find that bathing or skin contact produces THC metabolites in the body.

Test Studied

  • Urine THC immunoassay in a newborn nursery investigation

Suspected, but Not Proven

Furosemide

Source Ayala-Lopez et al., J Anal Toxicol 2022

What It Found

  • Patients with a record of furosemide use had more unconfirmed positive screens in one hospital study.
  • Adding furosemide to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.

Keep in Mind

  • A medication list records prior use.
  • It cannot identify what was in a particular specimen or which substance produced a signal.

Test Studied

  • Alere Integrated E-Z Split Key Cup II urine THC (cannabis or marijuana metabolites) screen

Meloxicam

Source Ayala-Lopez et al., J Anal Toxicol 2022

What It Found

  • Patients with a record of meloxicam use had more unconfirmed positive screens in one hospital study.
  • Adding meloxicam to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.
  • Its 5′-carboxy metabolite also tested negative up to 800 micrograms/mL.

Keep in Mind

  • A medication list records prior use.
  • It cannot identify what was in a particular specimen or which substance produced a signal.

Test Studied

  • Alere Integrated E-Z Split Key Cup II urine THC (cannabis or marijuana metabolites) screen

Tolmetin

Source Joseph et al., J Anal Toxicol 1995

What It Found

  • On the older EMIT method, known-positive cannabinoid samples containing tolmetin could read negative.

Keep in Mind

  • The mechanism and direction matter.
  • An instrument error or depressed signal is not evidence of a false-positive screen.
  • A separate high-concentration TDx benzodiazepine finding is indexed under benzodiazepines.

Tests Studied

  • Older Syva EMIT on Hitachi 704
  • Compared with Abbott TDx

Rifampin

Source la Porte et al., Ther Drug Monit 2006

What It Found

  • A clinical drug reference lists rifampin.
  • A phase 1 report involved efavirenz and rifampin, and the indexed record does not isolate a rifampin effect on the THC test.

Keep in Mind

  • Efavirenz has separate urine cannabinoid evidence.
  • Rifampin also has evidence on opiate assays that cannot establish THC interference.

Tests Studied

  • Cannabinoid screen
  • Reagent and independent rifampin challenge unverified

Tested: No False Positive Found

Hexahydrocannabiphorol

Source Schirmer et al., Drug Test Anal 2025

What It Found

  • One volunteer’s urine had HHCP metabolites on mass spectrometry and negative cannabinoid immunoassays.

Keep in Mind

  • One dose in one volunteer cannot establish nonreactivity of all HHCP products.
  • HHCP and HHC are distinct substances.

Test Studied

  • Urine enzyme immunoassays targeting delta-9 THC after one 4 mg oral HHCP dose

Source Höfert et al., Drug Test Anal 2024

What It Found

  • The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.

Keep in Mind

  • This refers to the compounds added in the laboratory.
  • A product can contain additional cannabinoids, and metabolism may introduce other analytes.

Test Studied

  • Study of commercial cannabinoid screens including urine test strips

Esomeprazole

Source Vohra et al., Clin Toxicol (Phila) 2020

What It Found

  • Urine samples stayed negative in the volunteers assigned to esomeprazole after five days of oral treatment in a small study of proton pump inhibitors.

Keep in Mind

  • Only one strip was used.
  • Few people took each medicine and adherence was not independently verified.

Test Studied

  • THC One Step Marijuana Test Strip

Lansoprazole

Source Vohra et al., Clin Toxicol (Phila) 2020

What It Found

  • Urine samples stayed negative in the volunteers assigned to lansoprazole after five days of oral treatment in a small study of proton pump inhibitors.

Keep in Mind

  • Only one strip was used.
  • Few people took each medicine and adherence was not independently verified.

Test Studied

  • THC One Step Marijuana Test Strip

Omeprazole

Source Vohra et al., Clin Toxicol (Phila) 2020

What It Found

  • Urine samples stayed negative in the volunteers assigned to omeprazole after five days of oral treatment in a small study of proton pump inhibitors.

Keep in Mind

  • Only one strip was used.
  • Few people took each medicine and adherence was not independently verified.

Test Studied

  • THC One Step Marijuana Test Strip

Acetaminophen

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Chocolate-associated ethanolamides

Source Tytgat et al., Int J Legal Med 2000

What It Found

  • None of three chocolate-associated lipids produced a positive result when added to urine.

Keep in Mind

  • This was a challenge with individual compounds, without an oral chocolate exposure group.

Test Studied

  • Urine cannabinoid immunoassay challenged with anandamide, oleoylethanolamide and linoleoylethanolamide

Dextromethorphan

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Diphenhydramine

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Hexahydrocannabinol acetate

Source Höfert et al., Drug Test Anal 2024

What It Found

  • The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.

Keep in Mind

  • This refers to the compounds added in the laboratory.
  • A product can contain additional cannabinoids, and metabolism may introduce other analytes.

Test Studied

  • Study of commercial cannabinoid screens including urine test strips

Meprobamate

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Nabilone

Source Fraser and Meatherall, J Anal Toxicol 1989

What It Found

  • The original publication reported no interference by nabilone with these urine cannabinoid methods.
  • Nabilone and dronabinol are different medicines.

Keep in Mind

  • These results apply to the evaluated methods.
  • The relevant target on a routine cannabis report is a THC metabolite.

Test Studied

  • EMIT d.a.u., Abbott TDx cannabinoid and a THC-metabolite TLC method

Prednisone

Source FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test…, 2025

What It Found

  • Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.

Keep in Mind

  • The manufacturer challenged the assay with parent prednisone.
  • This does not test all prednisone metabolites or predict the behavior of other devices.

Tests Studied

  • Healgen Accurate multi-drug urine dip card
  • The applicable target and cutoff are 50 ng/mL carboxy-THC

Tetrahydrocannabidiol

Source Höfert et al., Drug Test Anal 2024

What It Found

  • The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.

Keep in Mind

  • This refers to the compounds added in the laboratory.
  • A product can contain additional cannabinoids, and metabolism may introduce other analytes.

Test Studied

  • Study of commercial cannabinoid screens including urine test strips